CARE Ratings Q2 FY27 Consolidated Operating Income Rises 20% to ₹164.13 Crore; Declares Interim Dividend
CARE Ratings Limited reported a 20% YoY increase in consolidated operating income to ₹164.13 crore for Q2 FY27. Standalone operating income grew 17% YoY to ₹134.21 crore. Consolidated PAT rose 26% YoY to ₹72.37 crore. The Board declared an interim dividend of ₹10 per share. The company noted sustained momentum across its businesses.
The financial results show significant year-on-year growth across key metrics, indicating robust business performance. The declaration of an interim dividend is a direct positive financial event for shareholders. This suggests a strong operational and financial health of the company.
The company reported strong year-on-year growth in revenue, EBITDA, and PAT for both consolidated and standalone results for the quarter and half-year. The declaration of an interim dividend further supports a positive sentiment.
CARE Ratings Limited announced its unaudited financial results for the quarter and half-year ended September 30, 2026. For the second quarter of FY27, the consolidated operating income grew by 20% year-on-year to ₹164.13 crore. The Ratings Business contributed ₹148.51 crore (up 21% YoY), and the Non-Ratings Business contributed ₹15.62 crore (up 15% YoY). Consolidated EBITDA increased by 23% YoY to ₹84.61 crore, with a margin of 52%. Profit After Tax (PAT) grew by 26% YoY to ₹72.37 crore, maintaining a margin of 40%. Earnings Per Share (EPS) for the quarter stood at ₹23.88.
On a standalone basis for Q2 FY27, operating income was ₹134.21 crore, a 17% YoY increase. Standalone EBITDA rose by 20% YoY to ₹77.99 crore, with a margin of 58%. PAT increased by 24% YoY to ₹69.16 crore, with a margin of 46%. Standalone EPS was ₹22.98.
For the half-year ended September 30, 2026, consolidated operating income increased by 20% YoY to ₹275.81 crore. Consolidated EBITDA grew by 24% YoY to ₹119.25 crore (43% margin), and PAT increased by 26% YoY to ₹105.36 crore (34% margin). Consolidated EPS was ₹34.61.
Standalone operating income for H1 FY27 was ₹222.36 crore, up 17% YoY. Standalone EBITDA increased by 19% YoY to ₹110.09 crore (50% margin), and PAT grew by 21% YoY to ₹103.04 crore (41% margin). Standalone EPS was ₹34.25.
The Board of Directors also declared an interim dividend of ₹10 per share for the second quarter of FY27. The company's commentary highlights the resilience of the Indian economy and sustained momentum in its businesses, with both ratings and non-ratings segments reporting robust growth.
What to do with a filing like this
CARE Ratings Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by CARE Ratings Limited. Read the original for the full detail.